The total return over the past 12 months is -95.38% vs. +16.94% for the S&P 500. So far it's up -71.17% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (95.38%) | (59.51%) | (60.42%) | (46.85%) | N/A | N/A |
| Total Return CAGR | (95.38%) | (59.51%) | (60.42%) | (46.85%) | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Skye Bioscience, Inc. (SKYE)
| Year | Start price | End price | SKYE Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $6.00 | $1.73 | (71.17%) | +14.51% | (85.68%) |
| 2025 | $22.64 | $6.00 | (73.50%) | +17.72% | (91.22%) |
| 2024 | $21.76 | $22.64 | +4.04% | +24.89% | (20.85%) |
| 2023 | $32.00 | $21.76 | (32.00%) | +26.19% | (58.19%) |
| 2022 | $104.00 | $32.00 | (69.23%) | (18.17%) | (51.06%) |
| 2021 | $80.00 | $104.00 | +30.00% | +28.74% | +1.26% |
| 2020 | $262.00 | $80.00 | (69.47%) | +18.37% | (87.84%) |
| 2019 | $800.00 | $262.00 | (67.25%) | +31.22% | (98.47%) |
| 2018 | $304.00 | $800.00 | +163.16% | (4.56%) | +167.72% |
| 2017 | $604.00 | $304.00 | (49.67%) | +21.70% | (71.37%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
